Next Article in Journal
Aged to Perfection: The Scientific Symphony behind Port Wine, Vinegar, and Acetic Acid Bacteria
Next Article in Special Issue
Novel Lactic Acid Bacteria Strains from Regional Peppers with Health-Promoting Potential
Previous Article in Journal
The Production of Bioactive Hydroxytyrosol in Fermented Beverages: The Role of Must Composition and a Genetically Modified Yeast Strain
Previous Article in Special Issue
Protective Role of Limosilactobacillus fermentum Lf2 and Its Exopolysaccharides (EPS) in a TNBS-Induced Chronic Colitis Mouse Model
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Anti-Anemic and Anti-Dyspepsia Potential of Yogurt with Carao (Cassia grandis) in Rat Model

by
Jhunior Marcia
1,
Manuel de Jesús Álvarez Gil
2,
Héctor Zumbado Fernández
2,
Ismael Montero-Fernández
3,
Daniel Martín-Vertedor
4,
Ajitesh Yadav
5 and
Ricardo S. Aleman
6,*
1
Faculty of Technological Sciences, Universidad Nacional de Agricultura Road to Dulce Nombre de Culmi, Km 215, Barrio El Espino, Catacamas 16201, Honduras
2
Facultad de Farmacia y Alimentos, Universidad de la Habana, Habana 10300, Cuba
3
Department of Chemical Engineering and Physical Chemistry, Area of Chemical Engineering, Faculty of Sciences, University of Extremadura, Avda. de Elvas, s/n, 06006 Badajoz, Spain
4
Technological Institute of Food and Agriculture CICYTEX-INTAEX, Junta of Extremadura, Avda. Adolfo Suárez, s/n, 06007 Badajoz, Spain
5
Department of Food Science and Human Nutrition, Iowa State University, Ames Iowa, IA 50011, USA
6
School of Nutrition and Food Sciences, Louisiana State University Agricultural Center, Baton Rouge, LA 70808, USA
*
Author to whom correspondence should be addressed.
Fermentation 2024, 10(4), 199; https://doi.org/10.3390/fermentation10040199
Submission received: 4 February 2024 / Revised: 30 March 2024 / Accepted: 2 April 2024 / Published: 8 April 2024
(This article belongs to the Special Issue Recent Trends in Lactobacillus and Fermented Food, 2nd Edition)

Abstract

:
Iron deficiency anemia is a significant health problem in developing countries and this is rising, particularly in children and pregnant women. Several therapeutic properties have been attributed to Cassia grandis (carao), including the treatment against anemia, a laxative effect, and the reduction of bleeding. Yogurt is a vehicle for functional ingredients. As a result, this investigation aims to examine the application of Cassia grandis pulp as an anti-anemic and anti-dyspepsia agent in enriched yogurt. Carao pulp powder was added to milk at 0%, 0.5%, 1%, and 3% to produce yogurt. The bioavailability characteristics of iron deficiency anemia were analyzed in albino rats, which were studied for 4 weeks. Other groups of rats were used to set up the dyspepsia model by being fed a high-fat and high-calorie diet. Intestinal propulsion rate, gastric emptying rate, small intestinal contraction, motilin levels, and intestinal muscle tension were analyzed in rats with dyspepsia. Yogurt with 3% carao pulp powder restored ferritin, hemoglobin, total protein and iron at the end of the 4-week feeding period, with significant competition revealed in calcium and zinc absorbance. Furthermore, yogurt with 3% carao pulp powder improved intestinal propulsion rate, gastric emptying rate, small intestinal contraction, motilin levels, and intestinal muscle tension in dyspepsia rats. Carao can be recommended as an anti-anemia supplement in yogurt fortification.

1. Introduction

Cassia grandis, belonging to the Cesalpinoideae subfamily, also known as carao, sandalwood, and santal, is a tree native to Central America, the Caribbean, and northern South America [1]. The carao is a tree approximately 30 m high, with compound leaves, pink flowers with an internal yellow spot, and fruit as a woody pod [2]. This tree grows up to 900 m underwater in dry to humid weather. Carao leaves contain anthraquinones, boracol, flavonoids, leuco-anthocyanins, saponins, alkaloids, cardiotonic glycosides, sesquiterpene lactones, tannins, triterpenes, and iron [3]. The carao seed contains flavonoids, polysaccharides, toxic substances, and nutritional inhibitors. Among the latter are phytic acid and tannins [3]. It has been documented that the fresh carao leaf has anti-fungal activity against the Malassezia furfur fungus responsible for tinea versicolor or tinea versicolor [1]. Inhibition potential against the mite that causes scabies and against the virus that causes herpes [1] is also attributed to it. The leaves, flowers, and seeds have been reported to have purgative properties [3]. The flower also has anti-tussive characteristics and antipyretic activity. The bark can assist in treating rheumatism as a healing agent. An antiseptic liquid can be extracted from cassia grandis root and applied to disinfected wounds [1]. Alcoholic root extracts are also used for skin diseases. Central American and Caribbean popular culture has used the fruit’s pulp for different purposes, such as laxative, anti-tussive, hemorrhage inhibitor, aphrodisiac, menstrual regulator, anti-anemic, and anti-diabetic applications [1].
Yogurt is a food with a high nutritional density that is related to improving the overall diet quality [4]. This is due to its high content of essential ingredients, such as calcium, phosphorus, vitamins of group B, bioactive peptides, fatty acids, essential oils, and lactic acid bacteria (LAB), which complement its high biological value protein and fat content. All of these are part of a food matrix that favors the interaction between them, thus increasing their bioavailability and protecting them from degradation, thanks to their ability to form gels and their viscosity. In this sense, the matrix associates the bioactive peptides with oligosaccharides and fats. α-lactalbumin, β-lactoglobulin, and whey proteins interact with minerals, such as calcium, favoring its absorption [5]. The benefits associated with consuming yogurt seem to be more related to the effect of the matrix than to the impact of isolated nutrients [6]. Traditionally, yogurt consumption’s best-known and evidenced effects have been related to gastrointestinal (GI) health benefits [6]. Specifically, its role is highlighted in the treatment of infections, being related to an improvement in the symptoms of acute diarrhea and decreased stool frequency and duration of infection in children [7], as well as in certain diseases of an immuno-inflammatory nature, such as allergies [8] and inflammatory bowel disease (IBD) [9]. In addition, the European Food Safety Authority (EFSA) has recognized the use of the term probiotic for yogurt bacteria, thanks to its β-galactosidase activity, which helps the digestion of lactose and improves intestinal symptoms related to its intolerance [10].
Epidemiological and observational studies have revealed an association between yogurt consumption and metabolic benefits, such as enhanced body weight and adiposity [11] and managing type 2 diabetes [12]. At the same time, their effects on cardiovascular (CV) risk markers and the lipid profile appear neutral [13]. It should be noted that the consumption of other dairy products, such as milk, is not associated with similar effects on metabolism, despite containing a similar nutritional composition, thus suggesting that the milk matrix of the yogurt and its lactic ferments contribute to enhancing the beneficial effects of the nutrients of yogurt [14]. In this sense, yogurt consumption is related to a greater release of beneficial metabolites, such as amino and bile acids, compared with milk consumption [15], suggesting that fermentation is essential to produce metabolites with beneficial properties for human health. In some studies, the effect isolated from the consumption of yogurt can be masked by the inclusion of another type of dairy product in the intervention (milk, cheese, or butter) or by confounding factors that are associated with the consumption of yogurt, such as the practice of a balanced diet or physical activity [14]; however, certain studies show a positive association even after control for these factors [16], thus evidencing a stronger relationship between consumption of yogurt and metabolic benefits.
Paz et al. (2022) [17] and Fuentes et al. (2023) [18] indicated that carao improved the acid and bile tolerance of Streptococcus thermophilus, Lactobacillus delbrueckii ssp. bulgaricus, and Lactobacillus acidophilus [17,18]. Furthermore, in vitro and in vivo biological properties of yogurt supplemented with Cassia grandis showed the potential to treat diabetes mellitus-related disorders [19]. Some studies have indicated that carao yogurt improved glucose levels in diabetic-induced rats and has anti-inflammatory properties in caco2 cells [20]. Nevertheless, there is no research on the effects of yogurt supplemented with carao on anti-anemic and anti-dyspepsia effects. As a result, this investigation aims to examine the application of Cassia grandis pulp as an anti-anemic and anti-dyspepsia agent in enriched yogurt. This research aims to study the impact of yogurt fortified with the pulp of the Cassia grandis fruit on improving anti-anemic and anti-dyspepsia characteristics in animal models.

2. Materials and Methods

2.1. Plant Material and Extract Preparation

Between August and September 2022, carao fruit was collected from Catacamas Municipality, Olancho Department, Honduras (Latitude 14.84838° or 14°50′54″ north; Longitude −85.89356° or 85°53′37″ west). The plant material was manually separated from the whole fruit and was ground using a 501–700 mm knife mill (Retsch SM 100; Retsch GmbH, Haan, Germany). The milled pulp (200 g) was incorporated into 1 L of ethanol solution (97%) at a ratio of 8:2 (w/v). The hydroalcoholic solution was filtered through a Whatman # 1 filter paper, and the extract was then concentrated in a rotary evaporator (Rotavapor model 461, Büchi, Flawil, Switzerland). The obtained concentrated solution was lyophilized (Virtis Advantage Pro, SP Scientific, Warminster, PA, USA) and the freeze-dried product kept at room temperature [21].

2.2. Yogurt Preparation

Yogurt was prepared following the method of Aleman et al. (2023) [22] with slight modifications. Carao powder was added to milk (Great Value, Austin, TX, USA) at 3 different concentrations (0.5%, 1%, and 3%) and maintained under continuous mixing for 10 min at 50–55 °C. Whole milk (Great Value, Austin, TX, USA) was standardized to 12% (w/w) solids with powdered whole milk (Great Value, Austin, TX, USA). The milk was pasteurized at 85 °C for 30 min, then cooled to 42 °C, to add the starter culture (S. thermophilus ST-M5 and L. bulgaricus LB-12 (Chr. Hansen, Milwaukee, WI, USA) (1:1 ratio)) directly in a ratio of 3 mg/L of milk. The inoculated milk was incubated for 6 ± 1 h until reaching a pH of 4.5 ± 0.1, for subsequent cooling at 5 ± 1 °C. Yogurt was freeze-dried in a Free zone (Labconco, Kansas city, MI, USA) freeze-dryer unit for ~72 h [23].

2.3. Animals and Experimental Design

Male albino rats (n = 36) weighing 150 to 160 g were obtained from the Faculty of Biology, Universidad Nacional Autonoma de Honduras, Tegucigalpa (Honduras). The Ethics Committee in Food and Nutrition Research endorsed the experimentation protocol at the Honduran Association of Medicine and Nutrition (ASOHMENU) with form # AS-ASHOMENU-0012-2022. Animals were accommodated in cages at room temperature (22 ± 1 °C). For 1 week, rats were fed laboratory chow (protein 18.5%, fiber 11.2%, and fat 2.8%) and water ad libitum to stabilize the rat’s metabolic state. After the adaptation week, six groups of seven animals each were established (Figure 1) and randomly distributed. Group 1 consisted of healthy rats (Negative control group), and groups 2 through 6 were induced for anemia by providing for 2 weeks a diet having tannic acid (20 g/kg of body weight) [24]. Group 2 consisted of rats that were induced for anemia but were not fed with yogurt (Positive control group). After rats were induced with anemia, they were fed with free ferrous sulfate, ascorbic acid, and carao extract for 4 weeks, as described by Darwish et al. (2021) [24]. T1 (Group 3), provided yogurt fortified with 125 mgkg−1 ascorbic acid and 50 mgkg−1 free ferrous sulfate; T2 (Group 4), provided yogurt fortified with 125 mgkg−1 ascorbic acid, 50 mgkg−1 free ferrous sulfate, and 0.5% of carao pulp extract; T3 (Group 5), provided yogurt fortified with 125 mgkg−1 ascorbic acid, 50 mgkg−1 free ferrous sulfate, and 1% of carao pulp extract; and T4 (Group 6), provided yogurt fortified with 125 mgkg−1 ascorbic acid, 50 mgkg−1 free ferrous sulfate, and 3% of carao pulp extract. Once a week for 4 weeks, blood samples were obtained from rats’ eyes, and rats’ body weights were measured. Under light overnight fasting and diethyl ether anesthesia, rats were sacrificed after the 4 weeks of weight and blood examination. After the rats were sacrificed, blood samples were obtained from the abdominal aorta. Blood samples were centrifuged at 1800 RCF for 20 min at 4 °C, and serum was kept at −20 °C until further analysis. The heart, liver, kidney, and spleen were aseptically extracted and then set for 24 h in 10% (v/v) formalin after necropsy [24].
Furthermore, other groups of rats were used in a dyspepsia model and fed a high-fat and high-calorie diet. Rats were grouped as follows: drug group (DG), model group, normal group, and yogurt groups (T1, T2, T3, and T4). The rats in the normal group were given a standard diet, and the treatments were fed a high-fat and high-calorie diet, which was administrated with 52% milk from day 1 to day 4 of the experiment. Rats in the yogurt treatments (T1–T4) were provided with 0.3 g of yogurt per rat, and the DG were provided with 0.2 mL Jianweixiaoshi tablet solution (Yancheng, Jiangsu, China) per rat. The normal and model group rats were provided with 0.2 mL of saline solution per rat. T1 was provided with yogurt fortified with 125 mgkg−1 ascorbic acid and 50 mgkg−1 free ferrous sulfate; T2 was provided with yogurt fortified with 125 mgkg−1 ascorbic acid, 50 mgkg−1 free ferrous sulfate, and 0.5% of carao pulp extract; T3 was provided with yogurt fortified with 125 mgkg−1 ascorbic acid, 50 mgkg−1 free ferrous sulfate, and 1% of carao pulp extract; and T4 was provided with yogurt fortified with 125 mgkg−1 ascorbic acid, 50 mgkg−1 free ferrous sulfate, and 3% of carao pulp extract. The rats were sacrificed five days later [25].

2.4. Biochemical Analyses of Anemic Rats

All biochemical analyses were performed similarly to the manner prescribed in the Tietz Clinical Guide [26,27]. The complete blood cell count (RBCs, WBCs, Hb, Platelets, Hct, MCV, MCH, and MCHC) was determined. The automated method used the URIT-3000Vet-Plus equipment for the hematological analysis. First, a drop of blood was positioned on a slide sheet of around 10 microliters; another sheet was placed horizontally on the previous sheet at an angle of 45 degrees and slid horizontally. It was left to dry at room temperature. Then, the staining was performed for 7 min and observed in optical microscopy using immersion oil with a 100× objective to evaluate the total and differential number of leukocytes. The equipment was handled in the following way: once turned on and calibrated, the sample that would have previously passed through the mechanical shaker was positioned, and the examination began so that the machine performed the appropriate reading. The iron forms, such as total iron-binding capacity (TIBC), transferrin saturation (TS), and plasma iron, were examined. Furthermore, albumin, transferrin, ferritin, and the plasma total protein were examined. Zinc and calcium were also examined to consider their absorbance efficiency with iron. Plasma lipid and glucose profile, as well as kidney and liver function, were studied.

2.5. Analyses of Rats with Functional Dyspepsia

2.5.1. Gastric Emptying Rate and Small Intestine Propulsion Rate

Rats were given 5 g of self-made nutrition sodium carboxymethyl cellulose (semisolid paste), which was dissolved intra-gastrically in 125 mL of water. Whole milk powder (8 g) was then incorporated with activated carbon (2 g), soluble starch (4 g), and glucose (4 g), respectively. The stomach was extracted when mice were sacrificed by cervical dislocation. The weight of the residual substance in the stomach was measured, which was the difference between the net weight of the stomach and the weight of the stomach. The small intestine was also extracted, and the distances from the pylorus to the front of the black semi-solid paste and the pylorus to the ileocecal were estimated. The gastric emptying rate and small intestine propulsion rate were estimated as in Equations (1) and (2) [25].
Gastric emptying rate = 1 − ((Full stomach weight − Empty stomach weight)/(semisolid paste weight)) × 100%
Intestinal propulsive rate = (Charcoal powder advancing distance/Small intestine full length) × 100%.

2.5.2. Small Intestine Muscle Tension and Contraction Frequency

The intestine (2 to 3 cm) was extracted, and both ends of the intestine were tied (one connected to a tension sensor, the other fixed on the specimen hook). The intestine was incubated at 37 °C with 5% CO2 and 95% O2. The contraction activity curve was measured with the BL420 bio-functional experimental system. Motilin levels were measured following the kit protocol [25].

2.6. Statistical Analysis

Each experiment was carried out in triplicate or otherwise defined, and the mean and the standard deviations were determined. ANOVA One Way was used followed by Tukey’s HSD test using Statistical Analysis Systems SAS (SAS 9.4 Institute Inc., Cary, NC, USA). Significant differences were determined at α = 0.05.

3. Results and Discussion

3.1. Impact of Carao Fortified Yogurt Diet on Body and Relative Organ Weights

The relative weights of the spleen, kidney, liver, lungs, and heart of the albino rats as influenced by yogurt fortified with carao are presented in Table 1. The results showed that the relative body weights of the positive control group, the iron-deficiency anemia-induced rats (IDA), were hardly impacted, and showed a significant decrease. In contrast, the yogurt treatments (T1–T4) with fortified carao showed varied significant increases in the relative body weights compared to IDA rats. On the other hand, the plasma biochemical profile of the albino rats as influenced by yogurt fortified with carao is presented in Table 2.
Data regarding body weight and food consumption show great sensitivity in detecting alterations due to low toxicity [28]. The results indicated that yogurt fortified with carao did not cause major changes to the biochemical profile of the albino rats. Several therapeutic properties have been attributed to Cassia grandis (carao), including the laxative effect, reduction of bleeding, and treatment against anemia [29].

3.2. Monitoring Fortification Effects on Complete Blood Count

Figure 2 and Figure 3 show the complete blood count represented in white blood cells (containing lymphocytes, neutrophils, eosinophils, and monocytes), protein hemoglobin (Hb), platelets, and red blood cells (RBCs) of the rat groups over the 4 weeks of the study. The data revealed that the iron-deficiency anemia-induced rats were mirrored in all hematological parameters and lowered levels were indicated in the IDA groups compared to the healthy rats. Yogurt treatments enriched with carao gradually enhanced all hematological parameters in the 4 weeks of the study. This may be due to coating-dependent uptake, dose, and the amount of carao. Additionally, the carao’s Fe content may interlink with the results. Targeted functional ingredients are desired for delivery in cells, tissues and organs via local or systemic blood circulation, allowing the ingredients to act directly on the targeted illness sites and, therefore, more effectively generate remedial effects. The literature reports that the Cassia grandis has shown probiotic characteristics towards L. acidophilus [18]. Medical plants have also shown immuno-stimulant effects in albino rats with aqueous and methanolic extracts [30]. Essential oils have also shown antimicrobial activity in tuberculosis and S. aureus [31]. The hypoglycemic effect of carao has been studied carefully and shown to improve the hypoglycemic effect in diabetic rats [32]. In vivo studies have demonstrated the hypoglycemic properties of this plant [33]. Long-term ingestion of iron in large quantities can promote abnormal iron accumulation in the liver. The appearance of hemosiderin, similar to ferritin but with higher iron content and lower solubility, follows the saturation of the apoferritin supply. Hemosiderosis is an iron deposition condition; it occurs in individuals who abnormally consume large amounts of iron or by a genetic defect, resulting in excessive iron absorption [34]. By participating in iron storage, metabolism, and homeostasis, the liver stores iron in the cytoplasm of hepatocytes in ferritin or hemosiderin granules. The bundle, having among its functions the uptake and destruction of erythrocytes and the subsequent recovery of iron from hemoglobin, stores the iron in ferritin or hemosiderin for future reuse. Like the brain and liver, the bone marrow stores iron in ferritin and hemosiderin [35].

3.3. Fortification Effects on Serum Profile of Rat Groups

Figure 4 and Figure 5 illustrate the effect of enrichment on the rat groups’ serum protein and mineral profiles. Serum Fe parameters were negatively impacted, indicating marked reductions in the iron-deficiency anemia-induced rats (Figure 4). Yogurt supplemented with carao restored serum Fe levels with varied responses. The zinc and calcium levels were disproportionally associated with the carao enrichment levels (Figure 6). The Fe–Zn and Fe–Ca competition and interactions in absorbance have been previously studied; over a degree of “physiological” calcium intake, Fe absorption was disproportionally associated to calcium content in food [36]. Conversely, the serum protein profile illustrates different trends (Figure 5). The iron-deficiency anemia-induced rats presented the most inferior ferritin levels. Ferritin levels were significantly improved when treated with yogurt supplemented with carao. A similar trend was reported for transferrin and total protein.
However, the albumin levels were not significantly affected. If we analyze the ex vivo effect of the aqueous carao extract on smooth muscle, it can be concluded that it generally produces an increase in contraction. The specificity of smooth muscle is governed by the fact that different smooth muscles have different complements of agonist receptors. In many cases, a variety of different agonists can act on a single cell type, while some transmitters or hormones antagonize smooth muscle contraction and relaxation [37].
Abramson et al. (1988) [38] report that some anthraquinones induce the release of calcium from the sarcoplasmic reticulum in skeletal muscle. These authors explain that this effect is a direct consequence of the interaction between anthraquinones and the ryanodine receptor located in the membrane of the sarcoplasmic reticulum; therefore, it could be assumed that the active component contained in the aqueous carao extract does not bind to a receptor on the plasma membrane, if not to a cytosolic receptor. The aqueous extract of the pulp of the fruit of Cassia grandis, in addition to containing anthracene glycosides, contains cinnamic acid. The presence of said component in the aqueous carao extract had previously been identified by Hernández (1978) [39].
Cinnamic acid is a phenolic monomer found in a wide variety of plants [39]. After oral administration, it is excreted unchanged in the urine [40,41]. It has been reported that cinnamic acid is absorbed in the jejunum through different transport channels. Therefore, it is important to emphasize that plant extracts present several components in different proportions and that the compound found in the greatest quantity does not always produce the biological effect studied.

3.4. Fortification Effects on Gastric Emptying Rate, Intestinal Propulsion Rate, Intestinal Muscle Tension, and Small Intestinal Contraction Frequency

The small intestinal contraction frequency, intestinal propulsion rate, gastric emptying rate, and intestinal muscle tension in the model group decreased when compared with the healthy rats (Table 3). On the other hand, the gastric emptying rate, intestinal propulsion rate, intestinal muscle tension, and small intestinal contraction frequency in the yogurt treatments with carao and drug group increased when compared with the model group (Table 3).
Gastric emptying is a state that induces a delay in emptying food from the stomach into the duodenum, a complete embodiment of gastric motility. Slowed gastric emptying is the primary embodiment of gastrointestinal illnesses [42]. Rats were provided with high-calorie, high-protein foods to induce dyspepsia. The excessive consumption of high-calorie, high-protein foods inhibits normal function by reducing the gastrointestinal motility and transportation of the gastrointestinal tract.
The gastric emptying rate of mice with yogurt treatments and positive control were higher than the model group, suggesting that yogurt with carao has a positive impact and can stimulate gastric emptying. The small intestinal propulsive rate is associated with an increase in the duration of gastrointestinal mechanical movement and is one of the classical indexes of gastrointestinal mechanics. The gastric emptying hold and peristalsis delay are the primary pathophysiological causes of gastrointestinal motility illnesses [43]. The small intestine propulsion of mice with yogurt treatments and positive control were higher than the model group, suggesting that yogurt with carao has a positive impact and can improve gastrointestinal peristalsis function. ‘Motility disorders’ is an umbrella term that includes many illnesses that can impact the additional components of the gastrointestinal tract, and the gastrointestinal movement regulates peristalsis and segmentation [44].
The small intestine muscle tension of mice with yogurt treatments and positive control were higher than the model group, suggesting that yogurt with carao has a positive impact and can improve dyspepsia rat’s small intestine muscle tension. This observed effect could have occurred due to the action of the digestive enzymes of the intestine or the intestinal flora, which released or formed some compound that produced relaxation. In the literature, it has yet to be reported that the same extract presents two contrasting effects. However, Akomolafe et al. (2004) [45] reported that, in rats, the aqueous extract of Cassia podocarp produces colon contraction, while the methanolic extract produces relaxation of the colon and ileum.
In addition, the aqueous extract of Cassia acutifolia relaxes the colon and ileum, while the methanolic extract produces colon contraction. According to Kuo et al. (2000) [46], anthraquinones with a polar group, such as an amino, aldehyde, or carboxylic acid, significantly reduce intestinal motility. From the physiological point of view of smooth muscle contraction and relaxation, the relaxing effect observed with the aqueous extract of carao could also be explained through the negative feedback mechanism mediated by K+ channels activated by Ca2+, where the increase of calcium in the cytosolic space, determined by the previous increase in contraction, activates K+ channels that hyper-polarize the cell and promote relaxation [47,48,49].

4. Conclusions

The application of Cassia grandis pulp as an anti-anemic and anti-dyspepsia agent enriched in yogurt was investigated. Yogurt with 3% carao pulp powder improved hemoglobin, iron, ferritin, and total protein levels in albino rats at the 4-week feeding period, with considerable zinc and calcium absorbance. Furthermore, yogurt with 3% carao pulp powder improved gastric emptying rate, intestinal propulsion rate, intestinal muscle tension, small intestinal contraction, and motilin levels in dyspepsia rats. In summary, carao can be recommended as an anti-anemia supplement in yogurt fortification.

Author Contributions

Conceptualization, R.S.A. and J.M. methodology, R.S.A., M.d.J.Á.G., A.Y., H.Z.F. and J.M. software, R.S.A. and J.M. formal analysis, R.S.A., A.Y. and J.M. investigation, R.S.A., M.d.J.Á.G., H.Z.F., A.Y. and J.M. resources, R.S.A., J.M., I.M.-F. and D.M.-V.; data curation, I.M.-F., R.S.A. and D.M.-V.; writing—original draft preparation, R.S.A., J.M., D.M.-V. and I.M.-F. writing—review and editing, R.S.A., J.M., D.M.-V. and I.M.-F. project administration, R.S.A., J.M., D.M.-V. and I.M.-F. funding acquisition R.S.A., J.M., D.M.-V. and I.M.-F. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Junta de Extremadura (ref. GR21121—AGA008) and the European Regional Development Fund (FEDER) offered support. Furthermore, this work was supported by the Open Access Publishing Fund of the Free University National of Agriculture (Honduras), the International Development Research Center of Canada (IDRC) and the General Secretariat of the Council Central American University Superior (CSUCA) (Ref. C-DSIP-008-2023-UNAG).

Data Availability Statement

Data are contained within the article.

Acknowledgments

The authors thank the Research Support Service of the University of Extremadura. Finally, we appreciate the support of the University National of Agriculture (Honduras).

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Marcía-Fuentes, J.; Santos-Aleman, R.; Borrás-Linares, I.; Sánchez, J.L. The Carao (Cassia grandis L.): Its Potential Usage in Pharmacological, Nutritional, and Medicinal Applications. In Innovations in Biotechnology for a Sustainable Future; Maddela, N.R., García, L.C., Eds.; Springer: Cham, Switzerland, 2021; pp. 403–427. [Google Scholar]
  2. Fuentes, J.A.M.; López-Salas, L.; Borrás-Linares, I.; Navarro-Alarcón, M.; Segura-Carretero, A.; Lozano-Sánchez, J. Development of an Innovative Pressurized Liquid Extraction Procedure by Response Surface Methodology to Recover Bioactive Compounds from Carao Tree Seeds. Foods 2021, 10, 398. [Google Scholar] [CrossRef] [PubMed]
  3. Marcía-Fuentes, J.; Fernández, I.; Fernández, H.; Sánchez, J.; Alemán, R.; Alarcon, M. Quantification of bioactive molecules, minerals and bromatological analysis in carao (Cassia grandis). J. Agric. Sci. 2020, 12, 88. [Google Scholar]
  4. Wang, H.; Livingston, K.A.; Fox, C.S.; Meigs, J.B.; Jacques, P.F. Yogurt consumption is associated with better diet quality and metabolic profile in American men and women. Nutr. Res. 2013, 33, 18–26. [Google Scholar] [CrossRef]
  5. Svenning, C.; Brynhildsvold, J.; Molland, T.; Langsrud, T.; Elisabeth Vegarud, G. Antigenic response of whey proteins and genetic variants of β-lactoglobulin—The effect of proteolysis and processing. Int. Dairy J. 2000, 10, 699–711. [Google Scholar] [CrossRef]
  6. Thorning, T.K.; Bertram, H.C.; Bonjour, J.P.; de Groot, L.; Dupont, D.; Feeney, E.; Ipsen, R.; Lecerf, J.M.; Mackie, A.; McKinley, M.C.; et al. Whole dairy matrix or single nutrients in assessment of health effects: Current evidence and knowledge gaps. Am. J. Clin. Nutr. 2017, 105, 1033–1045. [Google Scholar] [CrossRef] [PubMed]
  7. Patro-Gołąb, B.; Shamir, R.; Szajewska, H. Yogurt for treating acute gastroenteritis in children: Systematic review and meta-analysis. Clin. Nutr. 2015, 34, 818–824. [Google Scholar] [CrossRef] [PubMed]
  8. Guarner, F. Impacts of prebiotics on the immune system and inflammation. In Diet, Immunity and Inflammation; Woodhead Publishing: Sawston, UK, 2013; pp. 292–312. [Google Scholar]
  9. Shadnoush, M.; Hosseini, R.S.; Mehrabi, Y.; Delpisheh, A.; Alipoor, E.; Faghfoori, Z.; Mohammadpour, N.; Moghadam, J.Z. Probiotic yogurt Affects Pro- and Anti-inflammatory Factors in Patients with Inflammatory Bowel Disease. Iran. J. Pharm. Res. IJPR 2013, 12, 929. [Google Scholar] [PubMed]
  10. Kies, A.K. Authorised EU health claims related to the management of lactose intolerance: Reduced lactose content, dietary lactase supplements and live yoghurt cultures. In Foods, Nutrients and Food Ingredients with Authorised EU Health Claims; Sadler, M.J., Ed.; Woodhead Publishing: Cambridge, UK, 2014; Chapter 9; pp. 177–211. [Google Scholar]
  11. Gijsbers, L.; Ding, E.L.; Malik, V.S.; de Goede, J.; Geleijnse, J.M.; Soedamah-Muthu, S.S. Consumption of dairy foods and diabetes incidence: A dose-response meta-analysis of observational studies. Am. J. Clin. Nutr. 2016, 103, 1111–1124. [Google Scholar] [CrossRef] [PubMed]
  12. Sayón-Orea, C.; Bes-Rastrollo, M.; Martí, A.; Pimenta, A.M.; Martín-Calvo, N.; Martínez-González, M.A. Association between yogurt consumption and the risk of metabolic syndrome over 6 years in the sun study. BMC Public Health 2015, 15, 170. [Google Scholar] [CrossRef] [PubMed]
  13. Dumas, A.-A.; Lapointe, A.; Dugrenier, M.; Provencher, V.; Lamarche, B.; Desroches, S. A systematic review of the effect of yogurt consumption on chronic diseases risk markers in adults. Eur. J. Nutr. 2017, 56, 1375–1392. [Google Scholar] [CrossRef] [PubMed]
  14. Fernandez, M.A.; Panahi, S.; Daniel, N.; Tremblay, A.; Marette, A. Yogurt and Cardiometabolic Diseases: A Critical Review of Potential Mechanisms. Adv. Nutr. 2017, 8, 812–829. [Google Scholar] [CrossRef] [PubMed]
  15. Pimentel, G.; Burton, K.J.; Von Ah, U.; Bütikofer, U.; Pralong, F.P.; Vionnet, N.; Portmann, R.; Vergères, G. Metabolic footprinting of fermented milk consumption in serum of healthy men. J. Nutr. 2018, 22, 67–73. [Google Scholar] [CrossRef] [PubMed]
  16. Mozaffarian, D. Dairy foods, obesity, and metabolic health: The role of the food matrix compared with single nutrients. Adv. Nutr. 2019, 10, 917S–923S. [Google Scholar] [CrossRef]
  17. Paz, D.; Aleman, R.S.; Cedillos, R.; Olson, D.W.; Aryana, K.; Marcia, J.; Boeneke, C. Probiotic Characteristics of Streptococcus thermophilus and Lactobacillus delbrueckii ssp. bulgaricus as Influenced by Carao (Cassia grandis). Fermentation 2022, 8, 499. [Google Scholar] [CrossRef]
  18. Marcia, J.; Aleman, R.S.; Montero-Fernández, I.; Martín-Vertedor, D.; Manrique-Fernández, V.; Moncada, M.; Kayanush, A. Attributes of Lactobacillus acidophilus as Effected by Carao (Cassia grandis) Pulp Powder. Fermentation 2023, 9, 408. [Google Scholar] [CrossRef]
  19. Aleman, R.S.; Moncada, M.; Aryana, K.J. Leaky Gut and the Ingredients That Help Treat It: A Review. Molecules 2023, 28, 619. [Google Scholar] [CrossRef] [PubMed]
  20. Aleman, R.S.; Marcia, J.; Page, R.; Kazemzadeh Pournaki, S.; Martín-Vertedor, D.; Manrique-Fernández, V.; Montero-Fernández, I.; Aryana, K. Effects of Yogurt with Carao (Cassia grandis) on Intestinal Barrier Dysfunction, α-glycosidase Activity, Lipase Activity, Hypoglycemic Effect, and Antioxidant Activity. Fermentation 2023, 9, 566. [Google Scholar] [CrossRef]
  21. Marcia, J.A.; Aleman, R.S.; Kazemzadeh, S.; Manrique Fernández, V.; Martín Vertedor, D.; Kayanush, A.; Montero Fernández, I. Isolated Fraction of Gastric-Digested Camel Milk Yogurt with Carao (Cassia grandis) Pulp Fortification Enhances the Anti-Inflammatory Properties of HT-29 Human Intestinal Epithelial Cells. Pharmaceuticals 2023, 16, 1032. [Google Scholar] [CrossRef] [PubMed]
  22. Aleman, R.S.; Page, R.; Cedillos, R.; Montero-Fernández, I.; Fuentes, J.A.M.; Olson, D.W.; Aryana, K. Influences of Yogurt with Functional Ingredients from Various Sources That Help Treat Leaky Gut on Intestinal Barrier Dysfunction in Caco-2 Cells. Pharmaceuticals 2023, 16, 1511. [Google Scholar] [CrossRef]
  23. Aleman, R.S.; Cedillos, R.; Page, R.; Olson, D.; Aryana, K. Physico-chemical, microbiological, and sensory characteristics of yogurt as affected by ingredients that help treat leaky gut. J. Dairy Sci. 2023, 106, 6. [Google Scholar] [CrossRef] [PubMed]
  24. Darwish, A.M.; Soliman, T.N.; Elhendy, H.A.; El-Kholy, W.M. Nano-encapsulated iron and folic acid-fortified functional yogurt enhance anemia in albino rats. Front. Nutr. 2021, 8, 654624. [Google Scholar] [CrossRef] [PubMed]
  25. Li, X.; Li, F.; Zhang, W.; Shen, S.; Wang, L.; Zhang, H.; Ding, M.; Chen, H.; Huang, M. Effect of Yogurt on Gastrointestinal Motility of Dyspepsia Mice. IOP Conf. Ser. Mater. Sci. Eng. 2019, 484, 012002. [Google Scholar] [CrossRef]
  26. Burtis, C.A.; Ashwood, E.R.; Saunders, W.B. Tietz Textbook of Clinical Chemistry, 3rd ed.; WB Saunders: Philadelphia, PA, USA, 1999; p. 283. [Google Scholar]
  27. Tietz, N.W. Clinical Guide to Laboratory Tests, 3rd ed.; W. B. Saunders: Philadelphia, PA, USA, 1995. [Google Scholar]
  28. Harwood, M.; Danielewska-Nikiel, B.; Borzelleca, J.F.; Flamm, G.W.; Williams, G.M.; Lines, T.C. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem. Toxicol. 2007, 45, 2179–2205. [Google Scholar] [CrossRef] [PubMed]
  29. Prada, A.L.; Achod, L.D.; Keita, H.; Carvalho, J.C.; de Souza, T.P.; Amado, J. Development, pharmacological and toxicological evaluation of a new tablet formulation based on Cassia grandis fruit extract. Sustain. Chem. Pharm. 2020, 16, 100244. [Google Scholar] [CrossRef]
  30. Nfambi, J.; Bbosa, G.S.; Sembajwe, L.F.; Gakunga, J.; Kasolo, J.N. Immunomodulatory activity of methanolic leaf extract of Moringa oleifera in wistar albino rats. J. Basic Clin. Physiol. Pharmacol. 2015, 26, 603–611. [Google Scholar] [CrossRef] [PubMed]
  31. Prada, A.L.; Keita, H.; de Souza, T.P.; Lima, E.S.; Acho, L.D.R.; da Silva, J.A.; Carvalho, J.C.T.; Amado, J.R.R. Cassia grandis Lf Nanodispersion is a hypoglycemic product with a potent α-glucosidase and Pancreatic Lipase Inhibitor Effect. Saudi Pharm. J. 2019, 27, 191–199. [Google Scholar] [CrossRef] [PubMed]
  32. Bona, E.; Massa, N.; Novello, G.; Pavan, M.; Rocchetti, A.; Berta, G.; Gamalero, E. Essential Oil Antibacterial Activity against Methicillin-Resistant and -Susceptible Staphylococcus aureus Strains. Microbiol. Res. 2019, 10, 8331. [Google Scholar] [CrossRef]
  33. Prada, A.L.; Amado, J.R.R.; Keita, H.; Zapata, E.P.; Carvalho, H.; Lima, E.S.; de Sousa, T.P.; Carvalho, J.C.T. Cassia grandis fruit extract reduces the blood glucose level in alloxan-induced diabetic rats. Biomed. Pharmacother. 2018, 103, 421–428. [Google Scholar] [CrossRef] [PubMed]
  34. Gee, M.; Mahan, L.K.; Escott-Stump, S. Weight management. Kirjassa Mahan LK Escott 2003, 7, 9–10. [Google Scholar]
  35. Ross, C.M. Quercetin, fruit consumption, and bone mineral density. Am. J. Clin. Nutr. 2005, 81, 1176. [Google Scholar] [CrossRef]
  36. Lonnerdal, B. Calcium and iron absorption–mechanisms and public health relevance. Int. J. Vitam. Nutr. Res. 2010, 80, 293–299. [Google Scholar] [CrossRef] [PubMed]
  37. Blaustein, M.P.; Kao, J.P.Y.; Matteson, D.R. Cellular Physiology and Neurophysiology, 2nd ed.; Elsevier: Philadelphia, PA, USA, 2011. [Google Scholar]
  38. Abramson, J.J.; Buck, E.; Salama, G.; Casida, J.E.; Pessah, I.N. Mechanism of anthraquinone-induced calcium release from skeletal muscle sarcoplasmic reticulum. J. Biol. Chem. 1988, 263, 18750–18758. [Google Scholar] [CrossRef]
  39. Hernández, E. Contribución al Estudio Fotoquimico de los Frutos de Carao (Cassia grandis L., Leguminosae). Bachelor’s Thesis, Universidad de Costa Rica, San Pedro Montes de Oca, San José, Costa Rica, 1978. [Google Scholar]
  40. Ando, H. Behavior of cinnamic acid and its derivates in the animal body. J. Biol. Chem. 1919, 38, 7–11. [Google Scholar] [CrossRef]
  41. Cremin, J.D., Jr.; McLeod, K.R.; Harmon, D.L.; Goetsch, A.L.; Bourquin, L.D.; Fahey, G.C., Jr. Portal and hepatic fluxes in sheep and con-centrations in cattle ruminal fluid of 3-(4-hydroxyphenyl)propionic, benzoic, 3-phenylpropionic, and trans-cinnamic acids. J. Anim. Sci. 1995, 73, 1766–1775. [Google Scholar] [CrossRef]
  42. Niu, X.; Zhang, Z.X. Physiology, 9th ed.; China Press of Traditional Chinese Medicine: Beijing, China, 2015. [Google Scholar]
  43. Hu, X.J.; Huang, S.P.; Deng, S.G. Effect of Decoction of Invigorating Spleen and Regulating Qi on Gastrointestinal Motility, Motilin and Gastrin in Rats with Functional Dyspepsia. Chin. J. Exp. Tradit. Med. Formulae 2011, 17, 217. [Google Scholar]
  44. Hu, J. Studies on Therapeutic Substances of Semen Crotonis Pulveratum on Bowel Movement and Anti-Endotoxin Activities of Wei-Chang-An-Wan. Master’s Thesis, Tianjin University, Tianjin, China, 2009. [Google Scholar]
  45. Akomolafe, R.O.; Adeoshun, I.O.; Ayoka, A.O.; Elujoba, A.A.; Iwalewa, E.O. An in vitro study of the effects of Cassia podocarpa fruit on the intestinal motility of rats. Phytomedicine 2004, 11, 249–254. [Google Scholar] [CrossRef] [PubMed]
  46. Kuo, D.H.; Kuo, S.C.; Cheng, J.T. Structure-activity relationships of anthraquinones in the decrease of intestinal motility. J. Pharm. Pharmacol. 2000, 52, 839–841. [Google Scholar] [CrossRef] [PubMed]
  47. Zhao, D.; Zhang, J.; Blaustein, M.P.; Navar, L.G. Attenuated renal vascular responses to acute angiotensin II infusion in smooth muscle-specific Na+/Ca2+ exchanger knockout mice. Am. J. Physiol.-Ren. Physiol. 2011, 301, F574–F579. [Google Scholar] [CrossRef] [PubMed]
  48. Antos, L.K.; Song, H.; Romar, L.; Griffith, B.P.; Pressley, T.A.; Blaustein, M.P. Ouabain Augments Agonist-Induced Ca2+ Signaling and Upregulates Ca2+ Transporter Expression in Human Arterial Smooth Muscle Cells. Hypertension 2010, 56, E144. [Google Scholar]
  49. Quast, U. Do the K+ channel openers relax smooth muscle by opening K+ channels? Trends Pharmacol. Sci. 1993, 14, 332–337. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Diagram of induced anemia and dyspepsia in animal models.
Figure 1. Diagram of induced anemia and dyspepsia in animal models.
Fermentation 10 00199 g001
Figure 2. Blood count of RBC (A), HB (B), WBC (C), Neut (D), Lymph/10 (E), Mono (F), Eosino (G), and plt100 (H) as influenced by yogurt fortified by carao. T1, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid; T2, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 0.5% of carao pulp extract; T3, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 1% of carao pulp extract; and T4, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 3% of carao pulp extract. If there no letters, no statistical difference was detected. Carao fortification is shown to improve the blood count of anemic rats. abcde Means are statistical different.
Figure 2. Blood count of RBC (A), HB (B), WBC (C), Neut (D), Lymph/10 (E), Mono (F), Eosino (G), and plt100 (H) as influenced by yogurt fortified by carao. T1, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid; T2, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 0.5% of carao pulp extract; T3, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 1% of carao pulp extract; and T4, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 3% of carao pulp extract. If there no letters, no statistical difference was detected. Carao fortification is shown to improve the blood count of anemic rats. abcde Means are statistical different.
Fermentation 10 00199 g002
Figure 3. Red cell index of Hct (A), Mkv (B), Mkh (C), and Mkhc (D) as influenced by yogurt fortified by carao. T1, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid; T2, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 0.5% of carao pulp extract; T3, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 1% of carao pulp extract; and T4, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 3% of carao pulp extract. If there no letters, no statistical difference was detected. abcd Means are statistical different.
Figure 3. Red cell index of Hct (A), Mkv (B), Mkh (C), and Mkhc (D) as influenced by yogurt fortified by carao. T1, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid; T2, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 0.5% of carao pulp extract; T3, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 1% of carao pulp extract; and T4, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 3% of carao pulp extract. If there no letters, no statistical difference was detected. abcd Means are statistical different.
Fermentation 10 00199 g003
Figure 4. Iron parameters of rat groups as influenced by yogurt fortified by carao. T1, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid; T2, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 0.5% of carao pulp extract; T3, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 1% of carao pulp extract; and T4, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 3% of carao pulp extract. ab Means are statistical different.
Figure 4. Iron parameters of rat groups as influenced by yogurt fortified by carao. T1, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid; T2, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 0.5% of carao pulp extract; T3, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 1% of carao pulp extract; and T4, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 3% of carao pulp extract. ab Means are statistical different.
Fermentation 10 00199 g004
Figure 5. Protein parameters of rat groups as influenced by yogurt fortified by carao. T1, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid; T2, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 0.5% of carao pulp extract; T3, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 1% of carao pulp extract; and T4, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 3% of carao pulp extract. If there no letters, no statistical difference was detected. abc Means are statistical different.
Figure 5. Protein parameters of rat groups as influenced by yogurt fortified by carao. T1, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid; T2, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 0.5% of carao pulp extract; T3, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 1% of carao pulp extract; and T4, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 3% of carao pulp extract. If there no letters, no statistical difference was detected. abc Means are statistical different.
Fermentation 10 00199 g005
Figure 6. Calcium concentration (A) and Zinc concentration (B) of rat groups as influenced by yogurt fortified by carao. T1, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid; T2, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 0.5% of carao pulp extract; T3, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 1% of carao pulp extract; and T4, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 3% of carao pulp extract. ab Means are statistical different.
Figure 6. Calcium concentration (A) and Zinc concentration (B) of rat groups as influenced by yogurt fortified by carao. T1, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid; T2, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 0.5% of carao pulp extract; T3, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 1% of carao pulp extract; and T4, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 3% of carao pulp extract. ab Means are statistical different.
Fermentation 10 00199 g006
Table 1. Fortified SFY impact on relative organ weights of treated rats.
Table 1. Fortified SFY impact on relative organ weights of treated rats.
ParametersNegative
Control
Positive
Control
T1T2T3T4
Total weight gain14.97 ± 4.49 a18.8 ± 4.25 a15.28 ± 3.31 a20.31 ± 5.97 a15.55 ± 3.45 a15.65 ± 3.39 a
Liver (Weight gain)3.35 ± 1.05 a3.65 ± 0.95 a4.05 ± 0.88 a3.36 ± 0.98 a3.58 ± 0.81 a3.25 ± 0.83 a
Kidney (Weight gain)0.59 ± 0.17 a0.68 ± 0.17 a0.79 ± 0.17 a0.76 ± 0.18 a0.72 ± 0.16 a0.70 ± 0.18 a
Spleen (Weight gain)0.49 ± 0.14 a0.66 ± 0.16 a0.83 ± 0.18 a0.69 ± 0.18 a0.78 ± 0.18 a0.62 ± 0.16 a
Heart (Weight gain)0.43 ± 0.13 a0.43 ± 0.15 a0.38 ± 0.08 a0.36 ± 0.09 a0.39 ± 0.11 a0.34 ± 0.09 a
Lungs (Weight gain)0.73 ± 0.29 a0.79 ± 0.15 a0.81 ± 0.17 a0.74 ± 0.26 a0.78 ± 0.14 a0.79 ± 0.22 a
Data represented are means of relative weights (g) (n = 5) ±SD. Means in the same row followed by different letters are significantly different (p ≤ 0.05). T1, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid; T2, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 0.5% of carao pulp extract; T3, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 1% of carao pulp extract; and T4, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 3% of carao pulp extract.
Table 2. Fortified SFY impact on plasma biochemical profile of treated rats.
Table 2. Fortified SFY impact on plasma biochemical profile of treated rats.
ParametersNegative ControlPositive ControlT1T2T3T4
Glucose mg dL−1193.08 ± 57.94 a160.55 ± 40.15 a178.25 ± 39.23 a175.75 ± 47.45 a182.85 ± 42.05 a161.25 ± 41.85 a
T.Ch. mg dL−175.97 ± 25.79 c79.34 ± 22.32 c101.01 ± 15.62 b103.84 ± 22.63 b95.26 ± 19.61 b123.31 ± 26.86 a
TG mg dL−1173.13 ± 51.94 b100.22 ± 25.05 a92.67 ± 15.98 a101.65 ± 27.44 a94.52 ± 21.74 a102.36 ± 31.85 a
HDL mg dL−130.49 ± 9.12 c42.75 ± 10.64 b43.72 ± 7.41 b40.13 ± 10.83 b38.21 ± 8.74 b48.45 ± 12.59 a
LDL mg dL−121.65 ± 6.48 b27.78 ± 6.94 a26.36 ± 5.79 a26.83 ± 7.24 a27.78 ± 6.39 a32.06 ± 8.33 a
AST mg IU−1185.72 ± 55.76 a203.73 ± 50.94 a167.91 ± 36.94 a180.26 ± 48.67 a161.97 ± 37.25 a164.58 ± 42.79 a
ALT mg IU−126.36 ± 7.90 a39.66 ± 9.91 a29.21 ± 6.42 a29.96 ± 10.76 a27.07 ± 6.22 a28.02 ± 7.27 a
ALP mg IU−1274.37 ± 82.29 a273.12 ± 68.27 a229.42 ± 50.47 a249.13 ± 67.26 a278.82 ± 64.12 a251.06 ± 65.26 a
T. Bilirubin g dL−10.28 ± 0.05 a0.22 ± 0.05 a0.19 ± 0.04 a0.21 ± 0.05 a0.27 ± 0.06 a0.22 ± 0.05 a
Urea mg dL−126.36 ± 7.90 a35.15 ± 8.78 a32.3 ± 7.1 a25.17 ± 6.79 a25.65 ± 5.88 a26.36 ± 6.85 a
Creatinine µmol0.93 ± 0.28 a0.92 ± 0.23 a0.91 ± 0.26 a0.93 ± 0.25 a0.92 ± 0.21 a0.93 ± 0.24 a
Means in the same row followed by different letters are significantly different (p ≤ 0.05). T1, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid; T2, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 0.5% of carao pulp extract; T3, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 1% of carao pulp extract; and T4, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 3% of carao pulp extract.
Table 3. Effect of yogurt on gastric emptying rate, intestinal propulsion rate, intestinal muscle tension, small intestinal contraction, and motilin level frequency in dyspepsia rats.
Table 3. Effect of yogurt on gastric emptying rate, intestinal propulsion rate, intestinal muscle tension, small intestinal contraction, and motilin level frequency in dyspepsia rats.
ParametersNormal GroupModel GroupDrug GroupT1T2T3T4
Gastric emptying rate46.12 ± 1.8 d34.60 ± 1.4 e62.20 ± 8.3 a54.60 ± 3.1 c55.76 ± 3.1 c56.65 ± 4.13 bc58.43 ± 1.45 b
Intestinal propulsion rate48.45 ± 3.1 a33.00 ± 8.3 e41.00 ± 1.4 b35.23 ± 3.2 d35.76 ± 1.3 d36.33 ± 2.45 d38.80 ± 1.6 c
Intestinal muscle tension0.14 ± 0.02 a0.08 ± 0.01 d0.16 ± 0.04 a0.11 ± 0.01 c0.12 ± 0.01 c0.12 ± 0.01 bc0.13 ± 0.01 b
Small intestinal contraction frequency6.25 ± 0.60 d6.00 ± 0.71 e7.56 ± 1.58 a7.46 ± 1.59 c7.48 ± 1.45 cb7.48 ± 1.27 cb7.50 ± 1.33 b
Motilin level 2023.77 ± 365.64 c1101.77 ± 275.75 b1221.19 ± 392.92 a1105.56 ± 223.57 b1045.56 ± 222.90 b1007.56 ± 257.88 b1001.56 ± 228.74 b
Means in the same row followed by different letters are significantly different (p ≤ 0.05). T1, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid; T2, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 0.5% of carao pulp extract; T3, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 1% of carao pulp extract; and T4, fed SFY fortified with 50 mgkg−1 free ferrous sulfate + 125 mgkg−1 ascorbic acid + 3% of carao pulp extract.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Marcia, J.; de Jesús Álvarez Gil, M.; Fernández, H.Z.; Montero-Fernández, I.; Martín-Vertedor, D.; Yadav, A.; Aleman, R.S. Anti-Anemic and Anti-Dyspepsia Potential of Yogurt with Carao (Cassia grandis) in Rat Model. Fermentation 2024, 10, 199. https://doi.org/10.3390/fermentation10040199

AMA Style

Marcia J, de Jesús Álvarez Gil M, Fernández HZ, Montero-Fernández I, Martín-Vertedor D, Yadav A, Aleman RS. Anti-Anemic and Anti-Dyspepsia Potential of Yogurt with Carao (Cassia grandis) in Rat Model. Fermentation. 2024; 10(4):199. https://doi.org/10.3390/fermentation10040199

Chicago/Turabian Style

Marcia, Jhunior, Manuel de Jesús Álvarez Gil, Héctor Zumbado Fernández, Ismael Montero-Fernández, Daniel Martín-Vertedor, Ajitesh Yadav, and Ricardo S. Aleman. 2024. "Anti-Anemic and Anti-Dyspepsia Potential of Yogurt with Carao (Cassia grandis) in Rat Model" Fermentation 10, no. 4: 199. https://doi.org/10.3390/fermentation10040199

APA Style

Marcia, J., de Jesús Álvarez Gil, M., Fernández, H. Z., Montero-Fernández, I., Martín-Vertedor, D., Yadav, A., & Aleman, R. S. (2024). Anti-Anemic and Anti-Dyspepsia Potential of Yogurt with Carao (Cassia grandis) in Rat Model. Fermentation, 10(4), 199. https://doi.org/10.3390/fermentation10040199

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop